Form 4 | Impact Biomedical Director Chan Heng Fai Ambrose sold 885,276 shares on April 2, 2025

Filings Track
05 Apr
Chan Heng Fai Ambrose, Director and a 10% owner of Impact Biomedical Inc., sold a total of 885,276 shares of common stock between April 2 to April 4, 2025, through his controlled entities Alset International Ltd and Alset Inc. Such intensive selling may suggest an overvaluation of the company's stock, and investors should closely monitor the potential impact of this news on the stock price.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10